Roles of adiponectin and oxidative stress in the regulation of membrane microviscosity of red blood cells in hypertensive men - An electron spin resonance study

Journal of Obesity

Volumn 2011, Issue , 2011, Pages

  Tsuda, Kazushi ^a,b  

^a KANSAI UNIVERSITY OF HEALTH SCIENCES   (Japan)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79751525839     PISSN: 20900708     EISSN: 20900716     Source Type: Journal    
DOI: 10.1155/2011/548140     Document Type: Article

References (42)

1. Kumada M., Kihara S., Sumitsuji S., Kawamoto T., Matsumoto S., Ouchi N., Arita Y., Okamoto Y., Shimomura I., Hiraoka H., Nakamura T., Funahashi T., Matsuzawa Y., Association of hypoadiponectinemia with coronary artery disease in men. Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 1 85 89 2-s2.0-0037231459 10.1161/01.ATV.0000048856.22331.50 (Pubitemid 36091630)
2. Ouchi N., Ohishi M., Kihara S., Funahashi T., Nakamura T., Nagaretani H., Kumada M., Ohashi K., Okamoto Y., Nishizawa H., Kishida K., Maeda N., Nagasawa A., Kobayashi H., Hiraoka H., Komai N., Kaibe M., Rakugi H., Ogihara T., Matsuzawa Y., Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension 2003 42 3 231 234 2-s2.0-10744223954 10.1161/01.HYP.0000083488. 67550.B8 (Pubitemid 37093465)
3. Adamczak M., Wiecek A., Funahashi T., Chudek J., Kokot F., Matsuzawa Y., Decreased plasma adiponectin concentration in patients with essential hypertension. American Journal of Hypertension 2003 16 1 72 75 2-s2.0-0037230545 10.1016/S0895-7061(02)03197-7 (Pubitemid 36078595)
4. Iwashima Y., Katsuya T., Ishikawa K., Ouchi N., Ohishi M., Sugimoto K., Fu Y., Motone M., Yamamoto K., Matsuo A., Ohashi K., Kihara S., Funahashi T., Rakugi H., Matsuzawa Y., Ogihara T., Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 2004 43 6 1318 1323 2-s2.0-2542473288 10.1161/01.HYP.0000129281.03801.4b (Pubitemid 38691756)
5. Furuhashi M., Ura N., Higashiura K., Murakami H., Tanaka M., Moniwa N., Yoshida D., Shimamoto K., Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension. Hypertension 2003 42 1 76 81 2-s2.0-0038818552 10.1161/01.HYP.0000078490.59735.6E (Pubitemid 36842239)
6. Ceriello A., Possible role of oxidative stress in the pathogenesis of hypertension. Diabetes Care 2008 31 supplement 2 S181 184 2-s2.0-41149116067
7. Elesber A. A., Best P. J., Lennon R. J., Mathew V., Rihal C. S., Lerman L. O., Lerman A., Plasma 8-iso-prostaglandin F2 α a marker of oxidative stress, is increased in patients with acute myocardial infarction. Free Radical Research 2006 40 4 385 391 2-s2.0-33644764866 10.1080/10715760500539154 (Pubitemid 43336043)
8. Cangemi R., Angelico F., Loffredo L., Del Ben M., Pignatelli P., Martini A., Violi F., Oxidative stress-mediated arterial dysfunction in patients with metabolic syndrome: effect of ascorbic acid. Free Radical Biology and Medicine 2007 43 5 853 859 2-s2.0-34547108613 10.1016/j.freeradbiomed.2007.06.002 (Pubitemid 47102131)
9. Dhawan V., Jain S., Effect of garlic supplementation on oxidized low density lipoproteins and lipid peroxidation in patients of essential hypertension. Molecular and Cellular Biochemistry 2004 266 1-2 109 115 2-s2.0-9444281486 10.1023/B:MCBI.0000049146.89059.53 (Pubitemid 39562311)
10. Rodrigo R., Prat H., Passalacqua W., Araya J., Guichard C., Bächler J. P., Relationship between oxidative stress and essential hypertension. Hypertension Research 2007 30 12 1159 1167 2-s2.0-38749104742 10.1291/hypres.30.1159 (Pubitemid 351176413)
11. Vassalle C., Botto N., Andreassi M. G., Berti S., Biagini A., Evidence for enhanced 8-isoprostane plasma levels, as index of oxidative stress in vivo, in patients with coronary artery disease. Coronary Artery Disease 2003 14 3 213 218 2-s2.0-0037614915 10.1097/00019501-200305000-00004 (Pubitemid 36578048)
12. Wang B., Pan J., Wang L., Zhu H., Yu R., Zou Y., Associations of plasma 8-isoprostane levels with the presence and extent of coronary stenosis in patients with coronary artery disease. Atherosclerosis 2006 184 2 425 430 2-s2.0-30044434546 10.1016/j.atherosclerosis.2005.05.008 (Pubitemid 43049730)
13. Sutherland W. H. F., Manning P. J., Walker R. J., De Jong S. A., Ryalls A. R., Berry E. A., Vitamin E supplementation and plasma 8-isoprostane and adiponectin in overweight subjects. Obesity 2007 15 2 386 391 2-s2.0-33947145568 (Pubitemid 46407320)
14. Panza J. A., Quyyumi A. A., Brush J. E. Jr., Epstein S. E., Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. New England Journal of Medicine 1990 323 1 22 27 2-s2.0-0025283892 (Pubitemid 20209468)
15. Node K., Kitakaze M., Yoshikawa H., Kosaka H., Hori M., Reduced plasma concentrations of nitrogen oxide in individuals with essential hypertension. Hypertension 1997 30 3 I 405 408 2-s2.0-0030802699 (Pubitemid 27446100)
16. Chen H., Montagnani M., Funahashi T., Shimomura I., Quon M. J., Adiponectin stimulates production of nitric oxide in vascular endothelial cells. Journal of Biological Chemistry 2003 278 45 45021 45026 2-s2.0-0242581695 10.1074/jbc.M307878200 (Pubitemid 37377262)
17. Tan K. C. B., Xu A., Chow W. S., Lam M. C. W., Ai V. H. G., Tam S. C. F., Lam K. S. L., Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation. Journal of Clinical Endocrinology and Metabolism 2004 89 2 765 769 2-s2.0-1442327754 10.1210/jc.2003-031012 (Pubitemid 38269891)
18. Loffredo L., Marcoccia A., Pignatelli P., Andreozzi P., Borgia M. C., Cangemi R., Chiarotti F., Violi F., Oxidative-stress-mediated arterial dysfunction in patients with peripheral arterial disease. European Heart Journal 2007 28 5 608 612 2-s2.0-34347230266 10.1093/eurheartj/ehl533 (Pubitemid 47355519)
19. Annuk M., Zilmer M., Lind L., Linde T., Fellström B., Oxidative stress and endothelial function in chronic renal failure. Journal of the American Society of Nephrology 2001 12 12 2747 2752 2-s2.0-0035204104 (Pubitemid 33115422)
20. Yamori Y., Nara Y., Horie R., Ooshima A., Abnormal membrane characteristics of erythrocytes in rat models and men with predisposition to stroke. Clinical and Experimental Hypertension 1980 2 6 1009 1021 2-s2.0-0019163357 (Pubitemid 11172183)
21. Tsuda K., Nishio I., Membrane fluidity and hypertension. American Journal of Hypertension 2003 16 3 259 261 2-s2.0-0037337889 10.1016/S0895-7061(02) 03257-0 (Pubitemid 36293074)
22. Zicha J., Kuneš J., Devynck M.-A., Abnormalities of membrane function and lipid metabolism in hypertension. American Journal of Hypertension 1999 12 3 315 331 2-s2.0-0033104357 10.1016/S0895-7061(98)00178-2 (Pubitemid 29147359)
23. Tsuda K., Iwahashi H., Minatogawa Y., Electron spin resonance studies of erythrocytes from spontaneously hypertensive rats and humans with essential hypertension. Hypertension 1987 9 6 19 24 2-s2.0-0023194616
24. Tsuda K., Kinoshita Y., Kimura K., Nishio I., Masuyama Y., Electron paramagnetic resonance investigation on modulatory effect of 17 β -estradiol on membrane fluidity of erythrocytes in postmenopausal women. Arteriosclerosis, Thrombosis, and Vascular Biology 2001 21 8 1306 1312 2-s2.0-0035572895 (Pubitemid 34219837)
25. Tsuda K., Nishio I., A selective estrogen receptor modulator, tamoxifen, and membrane fluidity of erythrocytes in normotensive and hypertensive postmenopausal women: an electron paramagnetic resonance investigation. American Journal of Hypertension 2005 18 8 1067 1076 2-s2.0-23744438080 10.1016/j.amjhyper.2005.02.009 (Pubitemid 41139905)
26. Tsuda K., Electron paramagnetic resonance investigation on modulatory effect of benidipine on membrane fluidity of erythrocytes in essential hypertension. Heart and Vessels 2008 23 2 134 139 2-s2.0-41949140755 10.1007/s00380-007-1017-6 (Pubitemid 351505881)
27. Tsuda K., Adiponectin and membrane fluidity of erythrocytes in normotensive and hypertensive men. Obesity 2006 14 9 1505 1510 2-s2.0-33846798249 10.1038/oby.2006.173 (Pubitemid 46214816)
28. Tsuda K., Oxidative stress and membrane fluidity of red blood cells in hypertensive and normotensive men: an electron Spin resonance investigation. International Heart Journal 2010 51 2 121 124 2-s2.0-0033659890 10.1536/ihj.51.121
29. +-ATPase activity. Nitric Oxide 2000 4 4 333 342 2-s2.0-0033845709 10.1006/niox.2000.0285 (Pubitemid 30664026)
30. Tsuda K., Kimura K., Nishio I., Masuyama Y., Nitric oxide improves membrane fluidity of erythrocytes in essential hypertension: an electron paramagnetic resonance investigation. Biochemical and Biophysical Research Communications 2000 275 3 946 954 2-s2.0-0034618743 10.1006/bbrc.2000.3408
31. Tsuda K., Kinoshita-Shimamoto Y., Kimura K., Nishio I., Nitric oxide is a determinant of membrane fluidity of erythrocytes in postmenopausal women: an electron paramagnetic resonance investigation. American Journal of Hypertension 2003 16 3 244 248 2-s2.0-0037336571 10.1016/S0895-7061(02)03261-2 (Pubitemid 36293072)
32. Le Quan Sang K.-H., Levenson J., Del Pino M., Simon A., Devynck M.-A., In vivo shear flow and erythrocyte membrane fluidity in hypertensive patients. British Journal of Clinical Pharmacology 1993 36 5 437 443 2-s2.0-0027482202 (Pubitemid 23344153)
33. Saldanha C., Sargenter L., Monteiro J., Perdigão C., Ribeiro C., Martins-Silva J., Impairment of the erythrocyte membrane fluidity in survivors of acute myocardial infarction. A prospective study. Clinical Hemorheology and Microcirculation 1999 20 2 111 116 2-s2.0-0032942834 (Pubitemid 29205145)
34. Cazzola R., Rondanelli M., Russo-Volpe S., Ferrari E., Cestaro B., Decreased membrane fluidity and altered susceptibility to peroxidation and lipid composition in overweight and obese female erythrocytes. Journal of Lipid Research 2004 45 10 1846 1851 2-s2.0-16644393180 10.1194/jlr.M300509-JLR200 (Pubitemid 40990876)
35. Lee A. G., Lipid-protein interactions in biological membranes: a structural perspective. Biochimica et Biophysica Acta 2003 1612 1 1 40 2-s2.0-0038364008 10.1016/S0005-2736(03)00056-7 (Pubitemid 36555684)
36. Kinnunen P. K. J., Kõiv A., Lehtonen J. Y. A., Rytömaa M., Mustonen P., Lipid dynamics and peripheral interactions of proteins with membrane surfaces. Chemistry and Physics of Lipids 1994 73 1-2 181 207 2-s2.0-0028136806 10.1016/0009-3084(94)90181-3 (Pubitemid 24299195)
37. Zou C.-G., Agar N. S., Jones G. L., Oxidative insult to human red blood cells induced by free radical initiator AAPH and its inhibition by a commercial antioxidant mixture. Life Sciences 2001 69 1 75 86 2-s2.0-0035946990 10.1016/S0024-3205(01)01112-2 (Pubitemid 32523936)
38. Lenfant F., Lahet J. J., Vergely C., Volot F., Freysz M., Rochette L., Lidocaine inhibits potassium efflux and hemolysis in erythrocytes during oxidative stress in vitro. General Pharmacology 2000 34 3 193 199 2-s2.0-0033659890 10.1016/S0306-3623(00)00060-4
39. Jubelin B. C., Gierman J. L., Erythrocyte may synthesize their own nitric oxide. American Journal of Hypertension 1996 9 12 I 1214 1219 2-s2.0-0030345756 10.1016/S0895-7061(96)00257-9 (Pubitemid 26423646)
40. Chen L. Y., Mehta J. L., Evidence for the presence of L-arginine-nitric oxide pathway in human red blood cells: relevance in the effects of red blood cells on platelet function. Journal of Cardiovascular Pharmacology 1998 32 1 57 61 2-s2.0-0031799860 10.1097/00005344-199807000-00009 (Pubitemid 28304694)
41. Xu A., Wang H., Hoo R. L. C., Sweeney G., Vanhoutte P. M., Wang Y., Wu D., Chu W., Qin G., Lam K. S. L., Selective elevation of adiponectin production by the natural compounds derived from a medicinal herb alleviates insulin resistance and glucose intolerance in obese mice. Endocrinology 2009 150 2 625 633 2-s2.0-59649117072 10.1210/en.2008-0999
42. Kondo K., Shibata R., rshibata@med.nagoya-u.ac.jp Unno K., Shimano M., Ishii M., Kito T., Shintani S., Walsh K., Ouchi N., Murohara T., Impact of a single intracoronary administration of adiponectin on myocardial ischemia/reperfusion injury in a pig model. Circulation: Cardiovascular Interventions 2010 3 2 166 173 2-s2.0-34249670301 10.1161/CIRCINTERVENTIONS.109. 872044